The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

Qsymia, Another Weight Loss Drug, Wins FDA Approval

by Dr. Sharon Orrange on September 4, 2012 at 2:00 pm

And away we go! Another weight loss drug, Qsymia, has won FDA approval.

Surprise! The “new” medication for weight loss is a combination of two existing medications. On the heels of Belviq, a weight loss medication approved a month ago, we now have a combination of phentermine and topiramate (Topamax) called Qsymia.

Qsymia is a combination of the FDA-approved drugs phentermine and topiramate (Topamax) in an extended-release formulation. Phentermine has been used for years for short-term weight loss and Topiramate is used for the treatment of seizures and the prevention of migraine headaches.

Here are the stats on Qsymia:

1. The average weight loss is about 9 – 10%.

2. The most common adverse reactions with Qsymia were tingling sensations of the hands and feet, dizziness, altered taste, insomnia, constipation, and dry mouth.

3. People who CAN’T use Qsymia are: those with glaucoma, hyperthyroidism or those with a history of heart disease or stroke.

4. If you don’t have weight loss after 12 weeks on Qsymia you should consider discontinuing it.

For those of you interested in prescription medications for weight loss you now have two new options: Qsymia and Belviq, which work by different mechanisms to help out with weight loss.

For more information on Belviq see my previous blog.

Dr O.

Qsymia is available in pharmacies as of September 2012.

Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.